» Articles » PMID: 29162880

FSCN1 Gene Polymorphisms: Biomarkers for the Development and Progression of Breast Cancer

Overview
Journal Sci Rep
Specialty Science
Date 2017 Nov 23
PMID 29162880
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

Breast cancer is a major cause of cancer mortality worldwide. Fascin-1 (FSCN1) is an actin-binding protein found in mammalian cells, including endothelial, neuronal and mesenchymal cells. FSCN1 overexpression has been indicated in breast cancer patients. However, scant information is available regarding the association between FSCN1 single nucleotide polymorphisms (SNPs) and the risk or prognosis of breast cancer. We report on the association between 6 SNPs of the FSCN1 gene (rs56156320, rs8772, rs3801004, rs2966447, rs852479 and rs1640233) and breast cancer susceptibility as well as clinical outcomes in 316 patients with breast cancer and in 222 healthy controls. Carriers of the AC or AC + CC allele of the variant rs56156320 were at greater risk of breast cancer compared with wild-type (AA) carriers. Moreover, carriers of at least one G allele in rs3801004 were likely to progress to stage III/IV disease and lymph node metastasis. Individuals with at least one T allele at FSCN1 SNP rs2966447 were at higher risk of developing pathologic grade G3 disease. Furthermore, individuals bearing the C/C haplotype at SNPs rs56156320 and rs3801004 had nearly twice the risk of breast cancer. Our results indicate that genetic variations in the FSCN1 gene may serve as an important predictor of early-stage breast cancer.

Citing Articles

The TRIM37 variant rs57141087 contributes to triple-negative breast cancer outcomes in Black women.

Tihagam R, Lou S, Zhao Y, Liu K, Singh A, Koo B EMBO Rep. 2024; 26(1):245-272.

PMID: 39614126 PMC: 11723928. DOI: 10.1038/s44319-024-00331-2.


The association of FSCN1 (rs852479, rs1640233) and HOTAIR (rs920778) polymorphisms with the risk of breast cancer in Egyptian women.

Galal E, Abdelhakam D, Ahmed L, Elhusseny Y, Sayed S, Eltaweel N Mol Biol Rep. 2024; 51(1):495.

PMID: 38587571 PMC: 11001669. DOI: 10.1007/s11033-024-09459-9.


Identification of prognostic risk score of disulfidptosis-related genes and molecular subtypes in glioma.

Jiang Q, Ling G, Yan J, Tan J, Nong R, Li J Biochem Biophys Rep. 2024; 37:101605.

PMID: 38188362 PMC: 10768521. DOI: 10.1016/j.bbrep.2023.101605.


Genetic Polymorphism in FSCN1 rs3801004 C/G and CD44 rs353639 A/C, as Prognostic Factor in Egyptian Breast Cancer Patients.

Ibrahim N, Hamed R, Refaat A, Mosaad Y, Mekawy D Asian Pac J Cancer Prev. 2023; 24(10):3517-3523.

PMID: 37898858 PMC: 10770661. DOI: 10.31557/APJCP.2023.24.10.3517.


Fascin-1 in Cancer Cell Metastasis: Old Target-New Insights.

Sarantelli E, Mourkakis A, Zacharia L, Stylianou A, Gkretsi V Int J Mol Sci. 2023; 24(14).

PMID: 37511011 PMC: 10379093. DOI: 10.3390/ijms241411253.


References
1.
Snyder M, Huang X, Zhang J . Signal transducers and activators of transcription 3 (STAT3) directly regulates cytokine-induced fascin expression and is required for breast cancer cell migration. J Biol Chem. 2011; 286(45):38886-93. PMC: 3234713. DOI: 10.1074/jbc.M111.286245. View

2.
Ghebeh H, Al-Khaldi S, Olabi S, Al-Dhfyan A, Al-Mohanna F, Barnawi R . Fascin is involved in the chemotherapeutic resistance of breast cancer cells predominantly via the PI3K/Akt pathway. Br J Cancer. 2014; 111(8):1552-61. PMC: 4200093. DOI: 10.1038/bjc.2014.453. View

3.
Shifman S, Bronstein M, Sternfeld M, Pisante-Shalom A, Weizman A, Reznik I . A highly significant association between a COMT haplotype and schizophrenia. Am J Hum Genet. 2002; 71(6):1296-302. PMC: 378567. DOI: 10.1086/344514. View

4.
Nagy R, Sweet K, Eng C . Highly penetrant hereditary cancer syndromes. Oncogene. 2004; 23(38):6445-70. DOI: 10.1038/sj.onc.1207714. View

5.
Amir E, Freedman O, Seruga B, Evans D . Assessing women at high risk of breast cancer: a review of risk assessment models. J Natl Cancer Inst. 2010; 102(10):680-91. DOI: 10.1093/jnci/djq088. View